Securities law firms are launching investigations and a class action lawsuit against Hercules Capital Inc. (NYSE: HTGC) after a critical report spurred a nearly 8 percent drop in the company’s stock on February 28, 2026.
"We’re investigating Hunterbrook’s allegations and, if true, whether Hercules misled investors about its sourcing, underwriting, marks, PIKs, and, ultimately its NAV," said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.
The lawsuit follows the publication of a report by Hunterbrook Media titled “The Myth of Hercules Capital,” which alleges the business development company overstated the quality of its loan origination and portfolio valuation. The report cites a former Hercules analyst who claimed the deal sourcing process amounted to copying investments from Google Ventures’ website.
The class action seeks to represent investors who purchased Hercules securities between May 1, 2025, and February 27, 2026. The lawsuit claims that, as a result of the company’s alleged misrepresentations, Hercules’ portfolio valuations and Net Asset Value were overstated, leading to investor losses. The lead plaintiff deadline is May 19, 2026.
Hunterbrook’s report also observed that about 35 percent of Hercules' loan portfolio value is exposed to the software sector, yet claims the company marks its software book at 100 cents on the dollar despite distress across the industry. It further alleged that a growing portion of Hercules' income is "phantom," derived from payment-in-kind (PIK) loans where interest is added to the principal balance rather than paid in cash.
The report also included information from a former member of Hercules' finance team, who raised concerns about the company's valuation process. Unlike other business development companies, the team was described as small and overstretched with few checks in place, according to Hunterbrook. Pomerantz LLP and the Law Offices of Howard G. Smith are among the other firms that have announced actions on behalf of investors.
The legal actions signal potential risk for current investors and create uncertainty around the company's reported financial health. Investors will be watching for the company's official response to the allegations and the progression of the lawsuit, with the May 19 lead plaintiff deadline serving as the next key date.
This article is for informational purposes only and does not constitute investment advice.